NCT04583904View on ClinicalTrials.gov

Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa

CompletedOBSERVATIONAL
Enrollment

843

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Tuberculosis
Trial Locations (1)

3201

Edendale Hospital, Pietermaritzburg

All Listed Sponsors
collaborator

Umkhuseli Innovation and Research Management (UIRM)

UNKNOWN

collaborator

University of KwaZulu

OTHER

collaborator

PATH

OTHER

collaborator

KwaZulu Natal Department of Health

UNKNOWN

collaborator

Salus Ltd.

INDUSTRY

lead

University of Washington

OTHER

NCT04583904 - Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa | Biotech Hunter | Biotech Hunter